Drug Profile
Measles vaccine - Bavarian Nordic
Alternative Names: Measles vaccine MVA mBN85B - Bavarian Nordic; MVA-BN Measles; MVA-mBN85BLatest Information Update: 22 Oct 2021
Price :
$50
*
At a glance
- Originator Bavarian Nordic
- Class Measles vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Measles
Most Recent Events
- 31 Aug 2010 Bavarian Nordic completes a phase II trial in Measles in South Africa (NCT00891007)
- 31 Mar 2010 Bavarian Nordic completes enrolment in its phase II trial for Measles in South Africa
- 29 Apr 2008 Immunogenicity data from a phase I trial in healthy volunteers and a preclinical trial in Measles released by Bavarian Nordic